ONdrugDelivery October Issue is now live which includes a contribution of AARDEX Group

AARDEX’s Scientific Lead Bernard Vrijens and Biocorp’s business development director Arnaud Guillet give some details about their companies alliance. They explain how Biocorp’s Injay connected prefilled syringe (PFS) combined with AARDEX’s MEMS Adherence Software provides a mean to tackle the issue of medication non-adherence in both clinical trials and commercialized drug products.

Low adherence to prescribed medication is a well-known issue to all healthcare stakeholders. Indeed, its clinical and commercial impact have been quantified and heavily documented for many years now.

“Strong evidence suggests that up to 50% of trial participants, including those in Phase II, III and IV studies, across most therapeutic areas, do not adhere to the protocol-specified dosing regimens.”

Both directors reflected on how to solve that huge issue. As a result, the collaboration between Biocorp and Aardex provides a unique opportunity to resolve it. The combined solution allows monitoring patient adherence to PFS in clinical trials and medical practice. Besides, it drives up engagement. Injay is easy to use, and its MEMS AS® companion app provides patient support. Not only through education and notifications but through behavioral advice also. Moreover, the solution provides healthcare professionals with all the information they need to remotely monitor a patient’s disease. Study teams get all the data they need to make risk-mitigation plans during clinical trials. In conclusion, with outcome-based financial compensation moving into the mainstream, it’s never been more important to take every opportunity to boost patients’ wellbeing.

Check out all the details given by the two speakers in the full article here.

Share This Post

You may also like...

Breaking News

Is Neglecting Medication Adherence in Neurology Drug Trials Putting Patients at Risk?

The list of Neurological conditions is considerable, with epilepsy, Alzheimer’s disease, dementia, stroke, migraine, multiple sclerosis, Parkinson’s disease, neuro infections, and brain tumors, all attributed to this category of disease. Hundreds of millions of people worldwide are affected by neurological

Bias in clinical Research
Breaking News

Unmasking Bias in Clinical Research: A Historical Perspective

It’s an uncomfortable truth that decision-making is a murky business. While we would all like to think that our actions and the choices underpinning them are rooted in logic, integrity, and reason, the truth is not entirely clear-cut. In reality,